Ross Prentice | Academic Influence

Ross Prentice's AcademicInfluence.com Rankings

Ross Prentice

Mathematics

#2257

World Rank

#3518

Historical Rank

Statistics

#83

World Rank

#113

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Ross Prentice's Degrees

PhD Statistics University of British Columbia
Masters Statistics University of British Columbia
Bachelors Mathematics University of British Columbia

Similar Degrees You Can Earn

Best Online Bachelor's in Math 2025

Why Is Ross Prentice Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ross L. Prentice is a Canadian statistician known particularly for his contributions to survival analysis and statistical methods for epidemiology. He has worked at the Fred Hutchinson Cancer Research Center in 1974 and is also a professor of biostatistics at the University of Washington School of Public Health.

(See a Problem?)

Ross Prentice's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial (2002) (14635)
The Statistical Analysis of Failure Time Data (1980) (8730)
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. (2004) (4327)
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. (1998) (2280)
The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical (2002) (2075)
Surrogate endpoints in clinical trials: definition and operational criteria. (1989) (1826)
Calcium plus vitamin D supplementation and the risk of fractures. (2006) (1778)
Commentary on Andersen and Gill's "Cox's Regression Model for Counting Processes: A Large Sample Study" (1982) (1568)
The analysis of failure times in the presence of competing risks. (1978) (1472)
A case-cohort design for epidemiologic cohort studies and disease prevention trials (1986) (1376)
Regression analysis of grouped survival data with application to breast cancer data. (1978) (1331)
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. (2007) (1330)
On the regression analysis of multivariate failure time data (1981) (1208)
Logistic disease incidence models and case-control studies (1979) (1147)
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. (2013) (1108)
Calcium plus vitamin D supplementation and the risk of colorectal cancer. (2006) (1003)
50-year trends in smoking-related mortality in the United States. (2013) (941)
Association analysis identifies 65 new breast cancer risk loci (2017) (922)
Correlated binary regression with covariates specific to each binary observation. (1988) (879)
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. (2006) (873)
Association of exogenous estrogen and endometrial carcinoma. (1975) (784)
Linear rank tests with right censored data (1978) (712)
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. (2006) (695)
Implementation of the Women's Health Initiative study design. (2003) (677)
Covariate measurement errors and parameter estimation in a failure time regression model (1982) (667)
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. (2006) (646)
Ethnicity and breast cancer: factors influencing differences in incidence and outcome. (2005) (617)
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) (2009) (578)
The Statistical Analysis of Failure Data (1986) (575)
Estrogen therapy and coronary-artery calcification. (2007) (562)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
Estimating equations for parameters in means and covariances of multivariate discrete and continuous responses. (1991) (544)
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. (2010) (536)
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. (2006) (525)
Marginal likelihoods based on Cox's regression and life model (1973) (509)
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 (2009) (502)
Correlated binary regression using a quadratic exponential model (1990) (498)
Estrogen plus progestin and risk of venous thrombosis (2004) (496)
Low-Fat Dietary Pattern and Weight Change Over 7 Years: The Women's Health Initiative Dietary Modification Trial (2006) (449)
Retrospective studies and failure time models (1978) (447)
Performance of common genetic variants in breast-cancer risk models. (2010) (430)
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. (2015) (425)
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. (2001) (406)
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. (2008) (373)
Smoking and Mortality - Beyond Established Causes. (2016) (372)
Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake. (2014) (369)
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials (2017) (366)
Breast cancer after use of estrogen plus progestin in postmenopausal women. (2009) (364)
Estimation of multiple relative risk functions in matched case-control studies. (1978) (345)
Asymptotic Distribution Theory and Efficiency Results for Case-Cohort Studies (1988) (344)
A generalization of the probit and logit methods for dose response curves. (1976) (344)
Binary Regression Using an Extended Beta-Binomial Distribution, with Discussion of Correlation Induced by Covariate Measurement Errors (1986) (332)
Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. (2008) (332)
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. (2005) (313)
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. (2013) (300)
Protein Intake and Incident Frailty in the Women's Health Initiative Observational Study (2009) (300)
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. (2005) (284)
Integrating the predictiveness of a marker with its performance as a classifier. (2007) (283)
Discovery of common and rare genetic risk variants for colorectal cancer (2018) (279)
Evaluation and comparison of food records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers. (2011) (279)
A LOG GAMMA MODEL AND ITS MAXIMUM LIKELIHOOD ESTIMATION (1974) (278)
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study (2012) (275)
Covariance and survivor function estimation using censored multivariate failure time data (1992) (266)
Smoking and mortality--beyond established causes. (2015) (264)
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. (2016) (250)
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. (2009) (239)
Exponential survivals with censoring and explanatory variables (1973) (229)
Use of the logistic model in retrospective studies. (1976) (225)
Residuals for relative risk regression (1988) (219)
Leukocyte counts and coronary heart disease in a Japanese cohort. (1982) (207)
Aspects of the rationale for the Women's Health Trial. (1988) (202)
Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus (2006) (199)
Meta-analysis of new genome-wide association studies of colorectal cancer risk (2012) (197)
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. (2007) (195)
Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. (2018) (192)
Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group. (1990) (192)
Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. (2011) (192)
Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. (2009) (191)
Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. (2013) (191)
Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for potassium and sodium intake. (2015) (190)
Measurement error and results from analytic epidemiology: dietary fat and breast cancer. (1996) (187)
A qualitative discrepancy between censored data rank tests. (1979) (187)
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. (2015) (186)
Survival analyses in twin studies and matched pair experiments (1974) (185)
Estimating equations for hazard ratio parameters based on correlated failure time data (1995) (183)
Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption (1990) (182)
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. (2006) (174)
Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor–Positive Breast Cancer (2011) (173)
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. (2020) (170)
Discrimination among some parametric models (1975) (170)
Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research. (1994) (166)
Conjugated equine estrogens and coronary heart disease : The women's health initiative (2006) (164)
Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. (2008) (162)
Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information (2010) (161)
Regression calibration in failure time regression. (1997) (160)
Likelihood inference in a correlated probit regression model (1984) (157)
A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. (2006) (157)
Hazard rate models with covariates. (1979) (155)
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. (2008) (151)
On the epidemiology of oral contraceptives and disease. (1987) (150)
Characterization of gene-environment interactions for colorectal cancer susceptibility loci. (2012) (149)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
Insights into colon cancer etiology via a regularized approach to gene set analysis of GWAS data. (2010) (147)
Aggregate data studies of disease risk factors (1995) (146)
Leukocyte counts and cerebrovascular disease. (1982) (141)
The Effects of Calcium Supplementation on Verified Coronary Heart Disease Hospitalization and Death in Postmenopausal Women: A Collaborative Meta‐Analysis of Randomized Controlled Trials (2015) (138)
Results of a randomized feasibility study of a low-fat diet. (1990) (137)
Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study. (2010) (135)
A Study of Distributional Shape in Life Testing (1977) (134)
Participant characteristics associated with errors in self-reported energy intake from the Women's Health Initiative food-frequency questionnaire. (2002) (132)
Weighted Estimators for Proportional Hazards Regression With Missing Covariates (2005) (130)
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. (2008) (129)
Asymptotic Distribution Theory for Cox-Type Regression Models with General Relative Risk Form (1983) (125)
Daily energy expenditure through the human life course (2021) (125)
A model to determine colorectal cancer risk using common genetic susceptibility loci. (2015) (121)
The women's health initiative: lessons learned. (2008) (116)
Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective. (2004) (114)
Dietary fat and breast cancer: a quantitative assessment of the epidemiological literature and a discussion of methodological issues. (1989) (113)
Nutrition and physical activity and chronic disease prevention: research strategies and recommendations. (2004) (111)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
Multivariate Mean Parameter Estimation by Using a Partly Exponential Model (1992) (109)
Semiparametric analysis of short-term and long-term hazard ratios with two-sample survival data (2005) (106)
Estimation of the average hazard ratio (1981) (105)
Semiparametric Inference in the Proportional Odds Regression Model (1999) (103)
Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease (2002) (102)
ASSOCIATION OF EXOGENOUS ESTROGEN AND ENDOMETRIAL CARCINOMA (1976) (100)
Dietary assessment and the reliability of nutritional epidemiology reports (2003) (99)
Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. (2011) (98)
Deaths Due to Cigarette Smoking for 12 Smoking-Related Cancers in the United States. (2015) (97)
Two-stage testing procedures with independent filtering for genome-wide gene-environment interaction. (2012) (97)
Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. (2009) (96)
Estrogen plus progestin and colorectal cancer incidence and mortality. (2012) (94)
Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women’s Health Initiative: A Longitudinal Study from the United States (2016) (94)
Biomarker‐Calibrated Protein Intake and Physical Function in the Women's Health Initiative (2013) (94)
Minimizing bias in randomized trials: the importance of blinding. (2010) (92)
On the design of synthetic case-control studies. (1986) (90)
A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. (1993) (88)
Approaches to monitoring the results of long-term disease prevention trials: Examples from the Women's Health Initiative (1996) (88)
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. (2016) (87)
Correcting “winner's curse” in odds ratios from genomewide association findings for major complex human diseases (2009) (87)
Improved Logrank‐Type Tests for Survival Data Using Adaptive Weights (2010) (85)
Statistical Issues Arising in the Women's Health Initiative (2005) (84)
Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women’s Health Initiative Observational Study (2014) (82)
Further results on covariate measurement errors in cohort studies with time to response data. (1989) (82)
Modern Statistical Methods in Chronic Disease Epidemiology. (1988) (81)
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
The Women's Health Trial Feasibility Study in Minority Populations: design and baseline descriptions. (1996) (79)
Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial. (2017) (78)
Increased Plasma Levels of the APC-Interacting Protein MAPRE1, LRG1, and IGFBP2 Preceding a Diagnosis of Colorectal Cancer in Women (2012) (78)
A risk set calibration method for failure time regression by using a covariate reliability sample (2001) (77)
Options for basing Dietary Reference Intakes (DRIs) on chronic disease endpoints: report from a joint US-/Canadian-sponsored working group123 (2016) (77)
Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling (2010) (74)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
Regression on hazard ratios and cross ratios in multivariate failure time analysis (1997) (73)
Indirect calorimetry protocol development for measuring resting metabolic rate as a component of total energy expenditure in free-living postmenopausal women. (2001) (72)
Regression Estimation Using Multivariate Failure Time Data and a Common Baseline Hazard Function Model (1997) (72)
Radiation exposure and thyroid cancer incidence among Hiroshima and Nagasaki residents. (1982) (72)
Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group. (1991) (71)
Biomarker-calibrated Energy and Protein Consumption and Cardiovascular Disease Risk Among Postmenopausal Women (2011) (70)
Maintenance of a low-fat diet: follow-up of the Women's Health Trial. (1992) (70)
Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort. (1984) (69)
What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking? (2015) (67)
Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort. (2017) (63)
Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis (2010) (63)
Evaluation of Known Oncoantibodies, HER2, p53, and Cyclin B1, in Prediagnostic Breast Cancer Sera (2012) (63)
Variation in the FGFR2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer (2009) (62)
Measurement Error Corrected Sodium and Potassium Intake Estimation Using 24-Hour Urinary Excretion (2014) (61)
Both Light Intensity and Moderate‐to‐Vigorous Physical Activity Measured by Accelerometry Are Favorably Associated With Cardiometabolic Risk Factors in Older Women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study (2017) (59)
Statistical design of the Women's Health Trial. (1988) (59)
Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study (2009) (59)
Low-fat dietary pattern and cardiovascular disease: results from the Women's Health Initiative randomized controlled trial. (2017) (58)
Chronic disease prevention: public health potential and research needs (2004) (57)
On the application of linear relative risk regression models. (1986) (57)
On assessing the strength of dependency between failure time variates (1996) (56)
An Analysis of Contaminated Well Water and Health Effects in Woburn, Massachusetts: Comment (1986) (56)
Physical activity assessment: biomarkers and self-report of activity-related energy expenditure in the WHI. (2013) (55)
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials (2014) (55)
Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women. (2013) (54)
Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trial (2018) (53)
Dependence Estimation Over a Finite Bivariate Failure Time Region (2000) (53)
Branched-chain amino acid, meat intake and risk of type 2 diabetes in the Women’s Health Initiative (2017) (52)
Women's Health Initiative (2014) (52)
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial. (2020) (52)
On the reliability and precision of within- and between- population estimates of relative rate parameters. (1995) (52)
Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. (2011) (51)
Biomarker-calibrated protein intake and bone health in the Women's Health Initiative clinical trials and observational study. (2014) (51)
Relationship of cigarette smoking and radiation exposure to cancer mortality in Hiroshima and Nagasaki. (1983) (51)
Applying Recovery Biomarkers to Calibrate Self-Report Measures of Energy and Protein in the Hispanic Community Health Study/Study of Latinos (2015) (50)
Perspective: Dietaryiomarkers of Intake and Exposure-Exploration with Omics Approaches. (2019) (50)
Quantifying Mediating Effects of Endogenous Estrogen and Insulin in the Relation between Obesity, Alcohol Consumption, and Breast Cancer (2012) (50)
Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3) (2018) (49)
Simultaneously testing for marginal genetic association and gene-environment interaction. (2012) (47)
Factors relating to eating style, social desirability, body image and eating meals at home increase the precision of calibration equations correcting self-report measures of diet using recovery biomarkers: findings from the Women’s Health Initiative (2013) (46)
The approximation of partial likelihood with emphasis on case-control studies (1980) (45)
Serial blood pressure measurements and cardiovascular disease in a Japanese cohort. (1982) (44)
Is high vitamin B12 status a cause of lung cancer? (2019) (44)
Potassium Intake and Risk of Stroke in Women With Hypertension and Nonhypertension in the Women’s Health Initiative (2014) (44)
Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings (2009) (44)
Combining a Food Frequency Questionnaire With 24-Hour Recalls to Increase the Precision of Estimation of Usual Dietary Intakes—Evidence From the Validation Studies Pooling Project (2018) (44)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (44)
The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women (2010) (44)
Design considerations for estimation of exposure effects on disease risk, using aggregate data studies. (1996) (43)
Simultaneous association of total energy consumption and activity-related energy expenditure with risks of cardiovascular disease, cancer, and diabetes among postmenopausal women. (2014) (43)
Evaluation of the 24-Hour Recall as a Reference Instrument for Calibrating Other Self-Report Instruments in Nutritional Cohort Studies: Evidence From the Validation Studies Pooling Project (2017) (42)
Energy compensation and adiposity in humans (2021) (42)
Postmenopausal estrogen and progestin effects on the serum proteome (2009) (41)
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women. (2014) (41)
Surrogate and mediating endpoints: current status and future directions. (2009) (41)
A standard calculation methodology for human doubly labeled water studies (2021) (40)
Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women's Health Initiative Dietary Modification Trial (2014) (40)
Cross-Species Antibody Microarray Interrogation Identifies a 3-Protein Panel of Plasma Biomarkers for Early Diagnosis of Pancreas Cancer (2015) (39)
Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users. (2010) (38)
Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers. (1991) (38)
Future possibilities in the prevention of breast cancer: Fat and fiber and breast cancer research (2000) (38)
An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis. (2015) (37)
Mixed Discrete and Continuous Cox Regression Model (2003) (37)
Cancer risk: Tumors excluded (2015) (36)
Tamoxifen as a potential preventive agent in healthy postmenopausal women. (1990) (36)
Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation. (2006) (36)
Migraine history and breast cancer risk among postmenopausal women. (2010) (36)
Serum Selenium, Genetic Variation in Selenoenzymes, and Risk of Colorectal Cancer: Primary Analysis from the Women's Health Initiative Observational Study and Meta-analysis (2011) (35)
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2020) (35)
On the ability of blood pressure effects to explain the relation between oral contraceptives and cardiovascular disease. (1988) (35)
The Influence of Obesity-Related Single Nucleotide Polymorphisms on BMI Across the Life Course (2013) (34)
Use of a Urinary Sugars Biomarker to Assess Measurement Error in Self-Reported Sugars Intake in the Nutrition and Physical Activity Assessment Study (NPAAS) (2014) (34)
Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index. (2015) (34)
Semiparametric Maximum Likelihood Estimation in Normal Transformation Models for Bivariate Survival Data. (2008) (34)
Combined association and aggregation analysis of data from case-control family studies (1998) (33)
Calibration of Self-Reported Dietary Measures Using Biomarkers: An Approach to Enhancing Nutritional Epidemiology Reliability (2013) (33)
On the use of case series to identify disease risk factors. (1984) (32)
The analysis of chromosomally aberrant cells based on beta-binomial distribution. (1984) (31)
The role of epidemiology in the era of molecular epidemiology and genomics: Summary of the 2013 AJE-sponsored Society of Epidemiologic Research Symposium. (2013) (31)
Dietary fat and breast cancer (1993) (31)
Postmenopausal Hormone Therapy and the Risks of Coronary Heart Disease, Breast Cancer, and Stroke (2014) (31)
Logistic Regression with Exposure Biomarkers and Flexible Measurement Error (2007) (31)
Relative risk and odds ratio regression. (1986) (31)
Characterization of 9p24 Risk Locus and Colorectal Adenoma and Cancer: Gene–Environment Interaction and Meta-Analysis (2010) (30)
Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements. (2007) (30)
Regression calibration in nutritional epidemiology: example of fat density and total energy in relationship to postmenopausal breast cancer. (2013) (29)
Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium (2019) (29)
Measurement error modeling and nutritional epidemiology association analyses (2011) (29)
Analysis of the costs of a large prevention trial. (1990) (29)
Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer. (2012) (29)
Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes (2019) (28)
Introduction to Cox (1972) Regression Models and Life-Tables (1992) (28)
Estrogen and colorectal cancer incidence and mortality (2015) (28)
Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy (2019) (28)
Hazard‐based nonparametric survivor function estimation (2004) (27)
Aspects of the use of relative risk models in the design and analysis of cohort studies and prevention trials. (1988) (27)
A Low-Fat Dietary Pattern and Diabetes: A Secondary Analysis From the Women’s Health Initiative Dietary Modification Trial (2017) (27)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (27)
Higher biomarker-calibrated protein intake is not associated with impaired renal function in postmenopausal women. (2011) (27)
Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases (2013) (27)
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects (2014) (27)
Serum Nitrogen and Carbon Stable Isotope Ratios Meet Biomarker Criteria for Fish and Animal Protein Intake in a Controlled Feeding Study of a Women's Health Initiative Cohort. (2018) (26)
Associations Between Incident Ischemic Stroke Events and Stroke and Cardiovascular Disease-Related Genome-Wide Association Studies Single Nucleotide Polymorphisms in the Population Architecture Using Genomics and Epidemiology Study (2012) (25)
Trans-ethnic fine-mapping of genetic loci for body mass index in the diverse ancestral populations of the Population Architecture using Genomics and Epidemiology (PAGE) Study reveals evidence for multiple signals at established loci (2017) (25)
On the use of historical control data to estimate dose response trends in quantal bioassay. (1992) (25)
On dependence estimation using correlated failure time data from case-control family studies (1999) (24)
Dietary Long‐Chain Fatty Acids and Carbohydrate Biomarkers Evaluation in a Controlled Feeding Study in Participants from the Women's Health Initiative Cohort (2017) (24)
A penalized EM algorithm incorporating missing data mechanism for Gaussian parameter estimation (2014) (24)
Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution. (2008) (23)
Variation in the FGFR2 Gene and the Effect of a Low-Fat Dietary Pattern on Invasive Breast Cancer (2010) (23)
Design issues in cohort studies (1995) (23)
Statistical Aspects of the Use of Biomarkers in Nutritional Epidemiology Research (2009) (23)
Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials (2007) (23)
Effects of smoking on the genetic risk of obesity: the population architecture using genomics and epidemiology study (2013) (22)
Change in Physical Activity and Sitting Time After Myocardial Infarction and Mortality Among Postmenopausal Women in the Women's Health Initiative‐Observational Study (2017) (22)
Competing Risks and Multistate Models (2011) (22)
Health issues of homeless persons. (1988) (22)
Discussion: On the role and analysis of secondary outcomes in clinical trials (1997) (22)
Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium (2017) (22)
Relationship Between Longitudinal Changes in Blood Pressure and Stroke Incidence (1984) (22)
Genetic architectures of proximal and distal colorectal cancer are partly distinct (2020) (21)
Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study (2017) (21)
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts (2018) (21)
Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populations123 (2017) (20)
Associations of Biomarker-Calibrated Sodium and Potassium Intakes With Cardiovascular Disease Risk Among Postmenopausal Women (2017) (20)
The renin-angiotensin aldosterone system and osteoporosis: findings from the Women’s Health Initiative (2019) (20)
Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women’s Health Initiative observational study (2012) (20)
Application of blood concentration biomarkers in nutritional epidemiology: example of carotenoid and tocopherol intake in relation to chronic disease risk. (2019) (20)
Relationships of Coronary Heart Disease With 27-Hydroxycholesterol, Low-Density Lipoprotein Cholesterol, and Menopausal Hormone Therapy (2012) (20)
Dietary assessment and the reliability of nutritional epidemiology research reports. (2010) (20)
Estimation of the 2-sample hazard ratio function using a semiparametric model. (2011) (19)
Validity of international, time trend, and migrant studies of dietary factors and disease risk. (1989) (19)
Invited commentary: ethics and sample size--another view. (2005) (19)
Sodium Intake and Osteoporosis. Findings From the Women's Health Initiative. (2016) (19)
Variation in event rates in trials of patients with type 2 diabetes. (2009) (18)
Hazard Ratio Estimation for Biomarker‐Calibrated Dietary Exposures (2012) (18)
Coronary Artery Calcification (CAC) and Post‐Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen‐Alone Trial (2017) (18)
Nonparametric correction for covariate measurement error in a stratified Cox model. (2004) (18)
Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study (2018) (18)
Dose-mortality relationships in RFM mice following 137Cs gamma-ray irradiation. (1982) (18)
Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3) (2020) (17)
Marginal and Conditional Models for the Analysis of Multivariate Failure Time Data (1992) (17)
Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial (2017) (17)
HLA and disease: relative-risk regression methods and multiple testing considerations. (1984) (17)
Designs for synthetic case-control studies in open cohorts. (1989) (17)
Reply to E Archer and SN Blair. (2015) (16)
Endometrial carcinoma: histopathology, survival, and exogenous estrogens. (1981) (16)
Observational studies, clinical trials, and the women’s health initiative (2007) (16)
Methodologic research needs in environmental epidemiology: data analysis. (1993) (16)
RECALIBRATION BASED ON AN APPROXIMATE RELATIVE RISK ESTIMATOR IN COX REGRESSION WITH MISSING COVARIATES (2001) (16)
Genetic risk factors for BMI and obesity in an ethnically diverse population (2012) (16)
Covariate measurement error correction methods in mediation analysis with failure time data (2014) (16)
Individually randomized intervention trials for disease prevention and control (1999) (16)
Regression Models and Multivariate Life Tables (2020) (15)
Randomized Trial Evaluation of Benefits and Risks of Menopausal Hormone Therapy Among Women Aged 50-59. (2020) (15)
Low-Fat Dietary Pattern and Cancer Mortality in the Women’s Health Initiative (WHI) Randomized Controlled Trial (2018) (15)
Tumor marker utility grading system. (1996) (15)
Associations of serum insulin-like growth factor-I and insulin-like growth factor-binding protein 3 levels with biomarker-calibrated protein, dairy product and milk intake in the Women's Health Initiative (2013) (15)
Opportunities for enhancing efficiency and reducing cost in large scale disease prevention trials: a statistical perspective. (1990) (14)
Assessing potentially time‐dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial (2015) (14)
Physical activity and fat-free mass during growth and in later life (2021) (14)
No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3) (2018) (14)
Nutritional epidemiology methods and related statistical challenges and opportunities (2018) (14)
Relative Risk (Cox) Regression Models (2011) (14)
Total energy expenditure measured using doubly labeled water compared with estimated energy requirements in older adults (≥65 y): analysis of primary data (2019) (14)
Associations of Biomarker-Calibrated Intake of Total Sugars With the Risk of Type 2 Diabetes and Cardiovascular Disease in the Women’s Health Initiative Observational Study (2018) (13)
Application of a New Statistical Model for Measurement Error to the Evaluation of Dietary Self-report Instruments (2015) (13)
Cohorts and consortia conference: a summary report (Banff, Canada, June 17–19, 2009) (2011) (13)
A generalisation of the Mantel—Haenszel test to bivariate failure time data (1996) (13)
Estimating Risk With Time-to-Event Data: An Application to the Women’s Health Initiative (2014) (13)
Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health Initiative (2017) (13)
Impaired functional vitamin B6 status is associated with increased risk of lung cancer (2018) (12)
Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). (2018) (12)
Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk (2012) (12)
A Model for Mortality Rates and a Test of Fit for the Gompertz Force of Mortality (1973) (12)
Overweight , Obesity , and Postmenopausal Invasive Breast Cancer Risk A Secondary Analysis of theWomen ’ s Health Initiative Randomized Clinical Trials (2015) (12)
Risk Factor Burden, Heart Failure, and Survival in Women of Different Ethnic Groups: Insights From the Women’s Health Initiative (2018) (12)
Estimation of the Correlation Between Nutrient Intake Measures Under Restricted Sampling (1999) (12)
Biostatistical issues and concepts in epidemiologic research. (1986) (12)
Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3) (2019) (12)
Data analysis methods and the reliability of analytic epidemiologic research. (2008) (12)
The Carbon Isotope Ratios of Serum Amino Acids in Combination with Participant Characteristics can be Used to Estimate Added Sugar Intake in a Controlled Feeding Study of US Postmenopausal Women. (2020) (11)
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk (2012) (11)
On non-parametric maximum likelihood estimation of the bivariate survivor function. (1999) (11)
Pooled versus individual genotyping in a breast cancer genome‐wide association study (2010) (11)
An Exploratory Study of Respiratory Quotient Calibration and Association with Postmenopausal Breast Cancer (2013) (11)
Case‐only approach to identifying markers predicting treatment effects on the relative risk scale (2018) (11)
Empirical evaluation of gene and environment interactions: methods and potential. (2011) (11)
Nonparametric tests of association between survival time and continuously measured covariates: the logit-rank and associated procedures. (1991) (10)
Biomarker-Calibrated Macronutrient Intake and Chronic Disease Risk among Postmenopausal Women. (2021) (10)
Forty‐year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women (2020) (10)
Abstract GS5-00: Long-term influence of estrogen plus progestin and estrogen alone use on breast cancer incidence: The Women's Health Initiative randomized trials (2020) (10)
Variation in the FGFR 2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer (2009) (10)
Invited Commentary on Pearl and Principal Stratification (2011) (10)
Research Strategies for Nutritional and Physical Activity Epidemiology and Cancer Prevention (2017) (10)
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk (2011) (10)
Rationale and design of cancer chemoprevention studies in Seattle. (1985) (9)
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
Self-Consistent Nonparametric Maximum Likelihood Estimator of the Bivariate Survivor Function. (2014) (9)
Methodologic challenges in chronic disease population research. (2001) (9)
The Role of Randomized Controlled Trials in Assessing the Benefits and Risks of Long‐Term Hormone Replacement Therapy: Example of the Women's Health Initiative (1996) (9)
On two-stage hypothesis testing procedures via asymptotically independent statistics (2010) (9)
Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50–59 Years of Age (2021) (9)
Approached to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative. (1996) (9)
Atomic Bomb Survivor Data: Utilization and Analysis. (1985) (9)
Prentice et al. Respond to “How Far Can Epidemiologists Get with Statistical Adjustment?” (2005) (9)
Relationship between dose of injected 239Pu and bone sarcoma mortality in young adult beagles. (1982) (8)
Nonparametric estimation of the multivariate survivor function: the multivariate Kaplan–Meier estimator (2018) (8)
Eating Pattern Response to a Low-Fat Diet Intervention and Cardiovascular Outcomes in Normotensive Women: The Women's Health Initiative (2020) (8)
Estimation of dependence between paired correlated failure times in the presence of covariate measurement error (2003) (8)
Covariate-adjusted dependence estimation on a finite bivariate failure time region (2002) (8)
Aspects of the science of cancer prevention trials: lessons from the conduct and planning of clinical trials of a low-fat diet intervention among women. (1991) (8)
Environmental epidemiology: risk assessment (1984) (8)
Dietary fat reduction as a hypothesis for the prevention of postmenopausal breast cancer, and a discussion of hypothesis testing research strategies. (1994) (8)
Dual Outcome Intention-to-treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials. (2020) (8)
Relative risk regression analysis of epidemiologic data. (1985) (8)
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. (2011) (7)
Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit. (2005) (7)
Sideroblastic anaemia in association with malignant histiocytosis. (2009) (7)
Towards personalized causal inference of medication response in mobile health: an instrumental variable approach for randomized trials with imperfect compliance (2016) (7)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
Discovery of common and rare genetic risk variants for colorectal cancer (2018) (6)
Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women's Health Initiative (WHI) randomized Dietary Modification trial (2020) (6)
Evaluation of potential metabolomic-based biomarkers of protein, carbohydrate and fat intakes using a controlled feeding study (2021) (6)
A statistical model for studying regional differences in observed mortality rates, and its application to Ontario during 1964-1968. (1976) (6)
Investigation of circular asymmetry in cancer mortality of Hiroshima and Nagasaki A-bomb survivors. (1983) (6)
Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
The Role of Intervention Studies in Ascertaining the Contribution of Dietary Factors in Lung Cancer (1988) (6)
Linear Measurement Error Models with Restricted Sampling (2007) (6)
Nutritional epidemiology and the Women's Health Initiative: a review. (2021) (6)
Factors Associated With New‐Onset Depression Following Ischemic Stroke: The Women's Health Initiative (2017) (6)
Degrees-of-freedom modifications for F tests based on nonnormal errors (1974) (6)
Higher Dimensional Clayton-Oakes Models for Multivariate Failure Time Data. (2016) (5)
Nonsteroidal Anti-Inflammatory Drug and Aspirin Use in Relation to Lung Cancer Risk among Postmenopausal Women (2015) (5)
Breast mammographic changes among women adopting a low-fat eating pattern. (1997) (5)
Incorporating Age at Onset Information into the Transmission/Disequilibrium Test (2001) (5)
Dietary Assessment and Opportunities to Enhance Nutritional Epidemiology Evidence (2020) (5)
Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer (2015) (5)
Women's health initiative studies of postmenopausal breast cancer. (2008) (5)
Chronic Disease Prevention Research Methods and Their Reliability, With Illustrations From the Women’s Health Initiative (2010) (5)
An Adjustment to Improve the Bivariate Survivor Function Repaired NPMLE (2005) (5)
Failure Time Models (2011) (5)
Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: response to Neupane (2014) (5)
Can dietary self-reports usefully complement blood concentrations for estimation of micronutrient intake and chronic disease associations? (2020) (5)
Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults (2021) (5)
Some further results on incorporating risk factor information in assessing the dependence between paired failure times arising from case‐control family studies: an application to prostate cancer (2002) (5)
Low-fat dietary pattern and long-term breast cancer incidence and mortality: The Women’s Health Initiative randomized clinical trial. (2019) (5)
Nontreatment and Aggressive Narcotic Therapy Among Hospitalized Pancreatic Cancer Patients (1998) (5)
Variability in energy expenditure is much greater in males than females. (2022) (4)
Human total, basal and activity energy expenditures are independent of ambient environmental temperature (2022) (4)
Variation in human water turnover associated with environmental and lifestyle factors (2022) (4)
Low-Fat Diet and Risk of Breast Cancer—Reply (2006) (4)
Covariate measurement errors in the analysis of cohort and case-control studies (1982) (4)
Regression analysis of censored survival data with extensions to include competing risks and case-control studies (1978) (4)
Rank Regression and the Accelerated Failure Time Model (2011) (4)
Fine mapping of 14q24.1 breast cancer susceptibility locus (2012) (4)
The Statistical Analysis of Multivariate Failure Time Data (2019) (4)
Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer (2022) (4)
Calcium supplements and cardiovascular risk in the Women’s Health Initiative: response to Bolland et al. (2013) (4)
Use of Intake Biomarkers in Nutritional Epidemiology (2017) (3)
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) (3)
Epidemiologic methods developments: a look forward to the year 2032. (2007) (3)
Low-Fat Diet and Cardiovascular Disease—Reply (2006) (3)
Dietary Biomarkers of Intake and Exposure: Exploration with Omics Approaches (2019) (3)
Novel application of nutritional biomarkers from a controlled feeding study and observational study toward dietary pattern characterization in postmenopausal women. (2021) (3)
Ethnicity and breast cancer in the Women's Health Initiative: A unifying concept for unfavorable outcome in African American women. (2004) (3)
The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women’s Health Initiative observational study (2018) (3)
Calcium plus vitamin D supplementation and the risk of fractures: Commentary (2006) (3)
Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region. (2022) (3)
Biomarkers for Components of Dietary Protein and Carbohydrate with Application to Chronic Disease Risk Among Postmenopausal Women. (2022) (3)
In the Women's Health Initiative Potassium Intake and Risk of Stroke in Women with Hypertension and Nonhypertension (2014) (3)
Response to “Calcium Supplements Increase Risk of Myocardial Infarction” (2015) (3)
Feasibility and importance of clinical trials of a low fat diet to reduce cancer risk. (1990) (3)
Contributions of the Women's Health Initiative to Cardiovascular Research: JACC State-of-the-Art Review. (2022) (3)
Protein Intake by Source and Breast Cancer Incidence and Mortality: The Women’s Health Initiative (2020) (3)
[Regression Models for Discrete Longitudinal Responses]: Comment (1993) (3)
1 Statistical Methods and Challenges in Epidemiology and Biomedical Research (2007) (3)
Total energy expenditure is repeatable in adults but not associated with short-term changes in body composition (2022) (3)
The goodness of fit of certain aging models. (1974) (3)
Research opportunities and needs in the study of dietary modification and cancer risk reduction: the role of biomarkers. (2006) (3)
Likelihood Construction and Further Results (2011) (3)
RE : DIETARY FAT AND BREAST CANCER. RESPONSE (1993) (3)
Intake biomarkers and the chronic disease nutritional epidemiology research agenda. (2018) (3)
Nonparametric Estimation of the Bivariate Survivor Function (2019) (2)
Characterization of 9 p 24 Risk Locus and Colorectal Adenoma and Cancer : Gene – Environment Interaction and Meta-Analysis (2010) (2)
Criteria for Acceptable Dietary Intake Biomarkers. (2022) (2)
Chemoprevention of Lung Cancer with Retinol/Beta-Carotene (1986) (2)
Estrogen alone and health outcomes in black women by African ancestry. (2015) (2)
Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women ' s Health Initiative Dietary Modi fi cation Trial (2014) (2)
Randomized Models and the Dilution and Bioassay Problems (1971) (2)
"Preventing breast cancer in postmenopausal women by achievable diet modification: a missed opportunity in public health policy" (Dayal HH and Kalia A, The Breast 2010; 19: 309-311). (2011) (2)
Inference in Parametric Models and Related Topics (2011) (2)
Biomarker-based Methods and Study Designs to Calibrate Dietary Intake for Assessing Diet-Disease Associations. (2021) (2)
On the accommodation of disease rate correlations in aggregate data studies of disease risk factors. (1998) (2)
Abstract CT043: Low-fat dietary pattern and breast cancer mortality in the Women's Health Initiative (WHI) randomized trial (2016) (2)
Obituary: Richard Doll (2005) (2)
Breast Cancer Risk FromModifiable and Nonmodifiable Risk Factors AmongWhiteWomen in the United States (2016) (2)
Hormone Therapy and Cardiovascular Risk—Reply (2007) (2)
Interpreting the Structural Model (1975) (2)
Women's health initiative view of estrogen avoidance and all-cause mortality. (2013) (2)
Dietary fat and cancer: rejoinder and discussion of research strategies (2004) (2)
Two-stage biomarker panel study and estimation allowing early termination for futility. (2015) (2)
Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapy (2013) (2)
On the Use of Biomarkers to Elucidate Clinical Trial Results: Examples from the Women’s Health Initiative (2013) (2)
Atomic bomb survivor data: utilization and analysis : proceedings of a conference sponsored by SIAM Institute for Mathematics and Society, and supported by the Department of Energy (1984) (2)
Terry fox cancer research workshop on prevention trials (1989) (2)
Reply to DR Merkle. (2018) (2)
Breast cancer outcome and estrogen plus progestin use in postmenopausal women. (2010) (2)
Dietary Moderation and Deaths From Breast Cancer. (2020) (2)
On the role, design, and analysis of disease prevention trials. (1995) (1)
Importance of Blinding in Randomized Trials—Reply (2010) (1)
Environmental epidemiology : risk assessment : proceedings of a conference (1982) (1)
Analysis of Correlated Failure Time Data (2011) (1)
Prentice et al. Respond to "Improving Estimation of Sodium Intake". (2017) (1)
Statistics and public health research (2014) (1)
Five authors reply [2] (2006) (1)
Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases (2013) (1)
Change to a Higher Carbohydrate Diet and Energy Expenditure among Postmenopausal Women. (2021) (1)
On the Role and Potential of High-Dimensional Biologic Data in Cancer Research (2009) (1)
Response to discussion of ‘Nutritional epidemiology methods and related statistical challenges and opportunities’ (2018) (1)
Asymptotic Properties of Semiparametric Maximum Likelihood Estimator in Normal Transformation Models for Bivariate Survival Data (Technical Report) (2008) (1)
Clinical validity assessment of a breast cancer risk model combining genetic and clinical information (2010) (1)
Discussion: Surrogate Endpoint Definition and Evaluation (2005) (1)
Aspects of the analysis of multivariate failure time data (2003) (1)
Estimating 24-Hour Urinary Excretion of Sodium and Potassium Is More Reliable from 24-Hour Urine Than Spot Urine Sample in a Feeding Study of US Older Postmenopausal Women (2021) (1)
Amendments and Corrections: Covariance and Survivor Function Estimation Using Censored Multivariate Failure Time Data (1993) (1)
FOUR AUTHORS REPLY (2008) (1)
Nonparametric estimation of the multivariate survivor function: the multivariate Kaplan–Meier estimator (2016) (1)
Systematic Reviews and Meta-and Pooled Analyses PooledResults From 5 ValidationStudies of Dietary Self-Report InstrumentsUsing Recovery Biomarkers for Potassium and Sodium Intake (2015) (1)
Survival Analysis: Overview (2001) (1)
Performance of Food Frequency Questionnaire, 4‐d food record and 24‐h dietary recall to measure total sugars (TS) against the urinary TS biomarker in postmenopausal women (36.4) (2014) (1)
Reproductive Factors, Oral Contraceptive Use, And Lung Cancer Risk Among Postmenopausal Women: The Women's Health Initiative (WHI) (2011) (1)
Low-Fat Diet and Weight Change in Postmenopausal Women—Reply (2006) (1)
DIETARY FAT AND BREAST CANCER. AUTHORS' REPLY (1998) (1)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (1)
Biomarker-calibrated Red and Combined Red and Processed Meat Intakes with Chronic Disease Risk in a Cohort of Postmenopausal Women. (2022) (1)
IMPLEMENTATION AND COMPUTATIONAL CONSIDERATIONS OF THE COX PARTIAL LIKELIHOOD ANALYSIS. (1983) (1)
Abstract S5-04: Low-fat dietary pattern and breast cancer overall survival in the women's health initiative dietary modification randomized controlled trial (2017) (1)
Intention-to-Treat Comparisons in Randomized Trials (2022) (1)
Methods for the analysis of time to failure data. (1983) (1)
Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk (2012) (1)
Measurement Error in Survival Analysis (2005) (1)
Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (1)
The association of predicted resting energy expenditure with risk of breast cancer among postmenopausal women in the Women's Health Initiative cohort. (2022) (1)
Robust methods to correct for measurement error when evaluating a surrogate marker (2020) (1)
Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium (2016) (1)
Reply to The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data (2020) (0)
Web-based Supplementary Materials for “ Improved Logrank-Type Tests for Survival Data Using Adaptive Weights ” by (2009) (0)
Univariate Failure Time Data Analysis Methods (2019) (0)
Women's Health Initiative: Statistical Aspects and Selected Early Results (2005) (0)
Sir Richard Doll on Chance and Genetic Susceptibility in Carcinogenesis, or, Why Not All Smokers Get Lung Cancer (2006) (0)
Trans-ethnic fine-mapping of genetic loci for body mass index in the diverse ancestral populations of the Population Architecture using Genomics and Epidemiology (PAGE) Study reveals evidence for multiple signals at established loci (2017) (0)
Linear Rank Tests (2014) (0)
Abstract 07: The effect of genetic variants on the relationship between statins and breast cancer in the Women's Health Initiative Observational Study. (2012) (0)
Abstract 933: Circulating biomarkers of B vitamins in relation to lung cancer risk in the Lung Cancer Cohort Consortium (2015) (0)
MARVIN ZELEN LEADERSHIP AWARD IN STATISTICAL SCIENCE AWARDEES (2013) (0)
Association of uncalibrated and calibrated energy and protein intakes with risk of diabetes in postmenopausal women (36.5) (2014) (0)
Feasibility of using spot urines as surrogates for 24‐hour urines to assess sodium and potassium excretion for CVD association studies (2016) (0)
Total daily energy expenditure has declined over the past three decades due to declining basal expenditure, not reduced activity expenditure (2023) (0)
Practice of Epidemiology Simultaneously Testing for Marginal Genetic Association and Gene-Environment Interaction (2011) (0)
Nonsteroidal Anti-In fl ammatory Drug and Aspirin Use in Relation to Lung Cancer Risk among Postmenopausal Women (2015) (0)
Fine mapping of 14q24.1 breast cancer susceptibility locus (2011) (0)
EDITORIALS Tumor Marker Utility Grading System (1996) (0)
Appendix B: Supporting Technical Material (2011) (0)
Associations Between Biomarker‐Calibrated Protein Intake and Bone Health in the Women's Health Initiative (2013) (0)
Low-fat diet and weight change in postmenopausal women. Authors' reply (2006) (0)
OP-JNCI200057 329..337 (2021) (0)
Four-day food record macronutrient intake, with and without biomarker calibration, and chronic disease risk in postmenopausal women. (2022) (0)
A low fat dietary pattern intervention did not reduce breast cancer, colorectal cancer, or CVD in postmenopausal women (2006) (0)
Gene-environment interactions in CRC risk loci 1 Title: Characterization of gene-environment interactions for colorectal cancer susceptibility loci Authors and Affiliations: (2012) (0)
65. Prevention Trials (2014) (0)
Hazard Rclte Models with Covariates (2016) (0)
A Functional Data Analysis Framework For Modeling Physical Activity Intensity Continuously Using Accelerometer Data (2020) (0)
Correction: Genetic variants in the MRPS30 region and postmenopausal breast cancer risk (2012) (0)
Multivariate Failure Time Data: Representation and Analysis (1997) (0)
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts (2018) (0)
Low-fat diet and cardiovascular disease. Authors' reply (2006) (0)
Tu-W28:3 The effects of an 8-year low-fat dietary pattern of cardiovascular disease (CVD) (2006) (0)
Rare Variant Association Methods and their Performance with Population Structure (2011) (0)
Abstract P170: Associations of Calibrated Dietary Sodium and Potassium Intakes With the Risk of Heart Failure and its Subtypes in Postmenopausal Women: The Women's Health Initiative (2018) (0)
What if Americans ate less fat? (1992) (0)
Trivariate Failure Time Data Modeling and Analysis (2019) (0)
Prentice et al. Respond to “Studying Co-Occurrence of Multiple Outcomes” (2020) (0)
Additional Failure Time Data Topics (2011) (0)
Mortality Associated with Healthy Eating Index Components and an Empirical-scores Healthy Eating Index in a Cohort of Postmenopausal Women. (2022) (0)
Introduction and Characterization of Multivariate Failure Time Distributions (2019) (0)
Genome-wide association study of germline variants and breast cancer-speci ﬁ c mortality (2019) (0)
Mortality Associated with Healthy Eating Index Components and an Empirical-Scores Healthy Eating Index in a Cohort of Postmenopausal Women. (2022) (0)
Abstract 2491: Dynamics changes in antigen-autoantibody profiles involving glycolysis and spliceosome proteins precede a diagnosis of ER+ and triple negative breast cancer among post-menopausal women. (2013) (0)
Counting Processes and Asymptotic Theory (2011) (0)
Rejoinder (2005) (0)
Reply to E Archer and SN Blair 1 (2015) (0)
4–5 Breast tumours following combined hormone replacement therapy express favourable prognostic factors (2008) (0)
A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium (2023) (0)
COVARIATE MEASUREMENT ERRORS IN THE ANALYSIS (2016) (0)
Coronary Heart Disease Relationships of Coronary Heart Disease With 27-Hydroxycholesterol, Low-Density Lipoprotein Cholesterol, and Menopausal Hormone Therapy (2012) (0)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
Development and validation of new predictive equations for resting metabolic rate (RMR) of older adults, aged 65 years and over. (2023) (0)
Total energy expenditure is repeatable in adults but not associated with short-term changes in body composition (2022) (0)
Serum Stable Isotope Biomarkers are Moderately Associated with Added Sugar, Fish and Meat Intake in 153 Postmenopausal Women (2017) (0)
Nutritional Epidemiology 1. Introduction 2. Research Designs and Methods 2.1. Hypothesis Development 2.2. Hypothesis Testing 2.2.1. Analytic Epidemiology Studies 2.2.2. Dietary Intervention and Nutritional Supplementation Trials 3. Example of Dietary Fat and Post-menopausal Breast Cancer 3.1. Hypoth (0)
Breast cancer risk from diet, tobacco, and alcohol. (1993) (0)
Biomarkers and the Risk of Stroke in the Women's Health Initiative (2011) (0)
Biomarkers for Components of Dietary Protein and Carbohydrate with Application to Chronic Disease Risk in Postmenopausal Women. (2022) (0)
Enhancing Capacity for Food and Nutrient Intake Assessment in Population Sciences Research. (2022) (0)
Estrogen and colorectal cancer incidence and mortality in the Women's Health Initiative clinical trial. (2013) (0)
The 2010 North American Menopause Society position statement on hormone therapy goes beyond the available evidence. (2012) (0)
Estrogen plus progestin (E+P) and breast cancer incidence and mortality. (2012) (0)
Low-fat dietary pattern and all cancer mortality in the Women's Health Initiative (WHI) randomized trial. (2018) (0)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
Abstract 818: Association of polygenic risk score and menopausal hormone therapy for colorectal cancer risk (2021) (0)
Low-fat diet and risk of breast cancer. Authors' reply (2006) (0)
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects (2014) (0)
Women's health and diet (1994) (0)
Testing gene-environment interactions in the presence of measurement error (2014) (0)
Rejoinder to “On the Misuse of Taylor Expansion” (2015) (0)
Total energy expenditure as assessed by doubly-labeled water and all-cause mortality in a cohort of postmenopausal females. (2023) (0)
Tibolone in older postmenopausal women. (2008) (0)
Epidemiology r esearch r eports (2010) (0)
Aspects of the Analysis and Reporting of Prevention Trials (2021) (0)
Response: Re: Low-Fat Dietary Pattern and Cancer Incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial (2008) (0)
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials (2020) (0)
Calibrated Total Sugars Intake and Risk of Type 2 Diabetes in the Women's Health Initiative Observational Study (2016) (0)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (0)
Appendix A: Some Sets of Data (2011) (0)
Modern statistical methods in chronic disease epidemiology : proceedings of a conference (1986) (0)
ESTIMATING FUNCTIONS IN FAILURE TIME DATA ANALYSIS (1997) (0)
Meta-analysis of new genome-wide association studies of colorectal cancer risk (2011) (0)
Practice of Epidemiology Regression Calibration in Nutritional Epidemiology : Example of Fat Density and Total Energy in Relationship to Postmenopausal Breast Cancer (2013) (0)
Breast cancer after stopping estrogen plus progestin in postmenopausal women in the women's health initiative. (2009) (0)
Protein Intake and Incident Frailty in the Women's Health Initiative Observational Study (2009) (0)
On the targets of inference with multivariate failure time data (2022) (0)
Modeling and Analysis of Recurrent Event Data (2011) (0)
Title Duration of Adulthood Overweight , Obesity , and Cancer Risk in the Women ' s Health Initiative : A Longitudinal Study from the United States Permalink (2016) (0)
Glossary of Notation (2011) (0)
Observational Studies and Intervention Trials in Exercise, Diet, and Cancer Prevention Research (2005) (0)
Cancer esearch ention and Epidemiology ection of Elevated Plasma Levels of Epidermal Growth tor Receptor Before Breast Cancer Diagnosis R ng Hormone Therapy Users (2010) (0)
Competing Risk Methods in Early Breast Cancer Trials (1979) (0)
Abstract LB-170: Breast cancer incidence and hormone therapy use before and after the Women’s Health Initiative (WHI) estrogen (E) plus progestin (P) trial by race/ethnicity (2019) (0)
Original Contribution Associations of Biomarker-Calibrated Sodium and Potassium Intakes With Cardiovascular Disease Risk Among PostmenopausalWomen (2017) (0)
Abstract 4733: Gene-set analysis of colon cancer genome-wide association data: Identification of the TGF-beta pathway (2010) (0)
Abstract 4825: Serum selenium concentration and risk of colorectal cancer in postmenopausal women: The Women's Health Initiative Observational Study (2010) (0)
Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements 1 – 4 (2006) (0)
Reply to WC Willett and D Ludwig. (2021) (0)
Research strategies for assessing epidemiolgic associations, in relation to the distribution and measurement of exposures (1998) (0)
Comment on: Low-Fat Dietary Pattern and Cancer Incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Authors' reply (2008) (0)
Abstract LB090: Associations of somatically mutated genes and pathways with colorectal cancer specific survival in 4,500 colorectal cancer patients (2021) (0)
Physical activity and fat-free mass during growth and in later life Doubly Labeled Water database (2021) (0)
Abstract 5102: Increased plasma levels of MAPRE1, an APC interacting protein, preceding a diagnosis of colorectal cancer (2011) (0)
Menopausal hormone therapy and breast cancer by body mass index (BMI) and African ancestry. (2014) (0)
Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2023) (0)
Response to Commentary on 'Dual Outcome Intention-To-Treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials'. (2020) (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
Women’s Health Initiative Dietary Modification Trial: Update and Application of Biomarker Calibration to Self-Report Measures of Diet and Physical Activity (2014) (0)
Demographic, Health and Lifestyle Factors Associated with the Metabolome in Older Women (2023) (0)
Rare loss of function variants in candidate genes and risk of colorectal cancer (2018) (0)
Practice of Epidemiology Use of Recovery Biomarkers to Calibrate Nutrient Consumption Self-Reports in the Women ’ s Health Initiative (2008) (0)
Using Controlled Feeding Study for Biomarker Development in Regression Calibration for Disease Association Estimation (2022) (0)
Genome-Wide Interaction Analysis of Genetic Variants with Menopausal Hormone Therapy for Colorectal Cancer Risk. (2022) (0)
Correction to: Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium (2017) (0)
Recurrent Event Data Analysis Methods (2019) (0)
Partly Exponential Models (2014) (0)
Meta-analysis of RCTS reporting on the coronary heart disease risk of calcium supplementation with or without vitamin D (2014) (0)
Abstract 4815: Elevated plasma levels of epidermal growth factor receptor prior to diagnosis of breast cancer in preclinical specimens from the Women's Health Initiative Observational Study (2010) (0)
Erratum To: Genetic variants in the MRPS30region and postmenopausal breast cancer risk (2012) (0)
Hormone therapy and cardiovascular risk. Authors' reply (2007) (0)
Biomarker‐calibrated estimates of self‐reported energy intake and risk of weight gain in postmenopausal women (272.1) (2014) (0)
Associations of Biomarker-Calibrated HEI-2010 Scores With Chronic Disease Risk and Their Dependency On Energy Intake and Body Mass Index in Postmenopausal Women. (2022) (0)
Opportunities and Needs in the Study of Dietary Modification and Cancer Risk Reduction : The Role of Biomarkers 1 , 2 (2006) (0)
of Epidemiology Novel Application of Nutritional Biomarkers From a Controlled Feeding Study and an Observational Study to Characterization of Dietary Patterns in Postmenopausal Women (2021) (0)
Regression Analysis of Bivariate Failure Time Data (2019) (0)
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women (2021) (0)
Higher Dimensional Failure Time Data Modeling and Estimation (2019) (0)
Assessing the validity of plasma phospholipid fatty acids as biomarkers of dairy fat intake using data from a randomized controlled intervention trial. (2022) (0)
PERSPECTIVES ON OBSERVATIONAL ANALYSES OF MEDICATION USE IN WHI COHORTS (2012) (0)
Hazard-based nonparametric survivor function (2004) (0)
Additional Important Multivariate Failure Time Topics (2019) (0)
Methodologic research needs in environmental epidemiology (1993) (0)
Study of Latinos: Nutrition & Physical Activity Assessment Study (SOLNAS) (130.6) (2014) (0)

This paper list is powered by the following services:

Other Resources About Ross Prentice

en.wikipedia.org

What Schools Are Affiliated With Ross Prentice?

Ross Prentice is affiliated with the following schools: